CY915A - Pyrrolo (3,4-b) pyrazine derivatives - Google Patents
Pyrrolo (3,4-b) pyrazine derivativesInfo
- Publication number
- CY915A CY915A CY915A CY91573A CY915A CY 915 A CY915 A CY 915A CY 915 A CY915 A CY 915A CY 91573 A CY91573 A CY 91573A CY 915 A CY915 A CY 915A
- Authority
- CY
- Cyprus
- Prior art keywords
- pyrrolo
- pyrazine derivatives
- pyrazine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7200505A FR2166314A1 (en) | 1972-01-07 | 1972-01-07 | 6-substd 5-(4-methyl 1-piperazinyl)carbonyloxy 7-oxo - 5,6-dihydro-pyrrolo (3,4-b)pyrazines - tranquillizers and anticonvuls |
FR7239731A FR2205318A2 (en) | 1972-11-09 | 1972-11-09 | 6-substd 5-(4-methyl 1-piperazinyl)carbonyloxy 7-oxo - 5,6-dihydro-pyrrolo (3,4-b)pyrazines - tranquillizers and anticonvuls |
Publications (1)
Publication Number | Publication Date |
---|---|
CY915A true CY915A (en) | 1977-12-23 |
Family
ID=26216824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY915A CY915A (en) | 1972-01-07 | 1973-01-05 | Pyrrolo (3,4-b) pyrazine derivatives |
Country Status (22)
Country | Link |
---|---|
US (1) | US3862149A (xx) |
JP (3) | JPS523952B2 (xx) |
AR (1) | AR195097A1 (xx) |
AT (1) | AT323181B (xx) |
AU (1) | AU466586B2 (xx) |
BE (1) | BE793730A (xx) |
CA (1) | CA991183A (xx) |
CY (1) | CY915A (xx) |
DD (1) | DD102698A5 (xx) |
DE (1) | DE2300491C3 (xx) |
DK (1) | DK139359B (xx) |
FI (1) | FI54124C (xx) |
GB (1) | GB1358680A (xx) |
HK (1) | HK60077A (xx) |
HU (1) | HU164821B (xx) |
IE (1) | IE37056B1 (xx) |
IL (1) | IL41232A (xx) |
LU (1) | LU66800A1 (xx) |
NL (1) | NL7217852A (xx) |
NO (1) | NO136843C (xx) |
OA (1) | OA04285A (xx) |
SE (1) | SE398503B (xx) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR208414A1 (es) * | 1974-11-07 | 1976-12-27 | Rhone Poulenc Ind | Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2) |
FR2322601A1 (fr) * | 1975-09-04 | 1977-04-01 | Rhone Poulenc Ind | Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent |
JPS5680585A (en) * | 1979-11-30 | 1981-07-01 | Toyoda Gosei Kk | High pressure hose |
JPS57144860A (en) * | 1981-03-04 | 1982-09-07 | Matsushita Electric Ind Co Ltd | Secondary side water pressure controller for water cooler |
DE3378763D1 (en) * | 1982-04-02 | 1989-02-02 | Takeda Chemical Industries Ltd | Condensed pyrrolinone derivatives, and their production |
JPS6169773A (ja) * | 1984-09-14 | 1986-04-10 | Takeda Chem Ind Ltd | イソインドリノン誘導体 |
JPS6297400U (xx) * | 1985-12-09 | 1987-06-20 | ||
FR2607504B1 (fr) * | 1986-12-02 | 1989-01-27 | Rhone Poulenc Sante | Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR2671800B1 (fr) * | 1991-01-17 | 1993-03-12 | Rhone Poulenc Rorer Sa | Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent. |
US5786357A (en) * | 1991-12-02 | 1998-07-28 | Sepracor Inc. | Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone |
WO1993010787A1 (en) * | 1991-12-02 | 1993-06-10 | Sepracor, Inc. | Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone |
WO1993010788A1 (en) * | 1991-12-02 | 1993-06-10 | Sepracor, Inc. | Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (-) zopiclone |
DE69910795T2 (de) | 1998-06-09 | 2004-06-17 | Takeda Chemical Industries, Ltd. | Pharmazeutische kombination mit einer trizyclischen verbindung und mindestens einer von zolpidem, zopiclone und brotizolam, zur behandlung oder verhinderung von schlafstörungen |
US6339086B1 (en) * | 1999-05-14 | 2002-01-15 | Swpracor, Inc. | Methods of making and using N-desmethylzopiclone |
ES2203319B1 (es) * | 2002-04-03 | 2005-03-01 | Universidad De Oviedo | Nuevos carbonatos opticamente activos como intermedios en la sintesis de (+)-zopiclona. |
PL1691811T3 (pl) | 2003-12-11 | 2014-12-31 | Sunovion Pharmaceuticals Inc | Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji |
EP1904046A4 (en) * | 2005-07-06 | 2008-10-01 | Sepracor Inc | COMBINATIONS OF ESZOPICLON AND O-DESMETHYLVENLAFAXINE AND METHOD FOR THE TREATMENT OF MENOPAUSE AND HUMOR FLUCTUATIONS; ANXIETY AND COGNITIVE INTERFERENCE |
CA2614282A1 (en) | 2005-07-06 | 2007-01-11 | Sepracor Inc. | Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
WO2007025177A2 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
US7476737B2 (en) * | 2005-09-05 | 2009-01-13 | Dr. Reddy's Laboratories Limited | Eszopiclone process |
EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
US20070112017A1 (en) * | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20070203145A1 (en) * | 2006-02-03 | 2007-08-30 | Jie Zhu | Zopiclone resolution |
US20070244143A1 (en) * | 2006-03-08 | 2007-10-18 | Braincells, Inc | Modulation of neurogenesis by nootropic agents |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US20080027223A1 (en) * | 2006-03-23 | 2008-01-31 | Teva Pharmaceutical Industries Ltd. | Polymorphs of eszopiclone malate |
US20070270590A1 (en) * | 2006-04-20 | 2007-11-22 | Marioara Mendelovici | Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone |
CN101058581B (zh) * | 2006-04-21 | 2011-06-08 | 天津天士力集团有限公司 | 右佐匹克隆中间体6-(5-氯-2-吡啶基)-5,7-二氧代-6,7-二氢-5H-吡咯并[3,4-b]吡嗪的制备方法 |
US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US20080015197A1 (en) * | 2006-06-26 | 2008-01-17 | Alex Mainfeld | Process for the preparatrion of zopiclone |
MX2009002496A (es) * | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
EP2066355A2 (en) * | 2006-09-19 | 2009-06-10 | Braincells, Inc. | Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis |
US7786304B2 (en) * | 2006-11-06 | 2010-08-31 | Centaur Pharmaceutical Pvt. Ltd. | Process for the preparation of eszopiclone |
EP2032557A2 (en) * | 2007-01-31 | 2009-03-11 | Teva Pharmaceutical Industries Ltd. | Methods for preparing eszopiclone |
US20080305171A1 (en) * | 2007-06-07 | 2008-12-11 | Kristin Anne Arnold | Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there |
US20090018336A1 (en) * | 2007-06-25 | 2009-01-15 | Nina Finkelstein | Racemization process of R-zopiclone |
EP2020403A1 (en) | 2007-08-02 | 2009-02-04 | Esteve Quimica, S.A. | Process for the resolution of zopiclone and intermediate compounds |
WO2009063486A2 (en) * | 2007-08-06 | 2009-05-22 | Usv Limited | Process for preparation of dextrorotatory isomer of 6-(5-chloro-pyrid-2-yi)-5-[(4-methyl -1-piperazinyl) carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo [3,4-b] pyrazine (eszopiclone) |
AU2008346110A1 (en) * | 2007-12-11 | 2009-07-16 | Cipla Ltd. | Crystalline polymorphic forms of zopiclone, processes for their preparation and their pharmaceutical compositions |
WO2009085988A1 (en) * | 2007-12-19 | 2009-07-09 | Sepracor Inc. | Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7- dihydro-5h-pyrrolo[3,4-b]pyrazine |
US8212036B2 (en) | 2007-12-19 | 2012-07-03 | Sunovion Pharmaceuticals Inc. | Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8198277B2 (en) * | 2007-12-19 | 2012-06-12 | Sunovion Pharmaceuticals Inc. | L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8198278B2 (en) * | 2007-12-19 | 2012-06-12 | Sunovion Pharmaceuticals Inc. | Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
CN100467471C (zh) * | 2007-12-19 | 2009-03-11 | 齐鲁天和惠世制药有限公司 | 佐匹克隆的制备方法 |
US8269005B2 (en) * | 2007-12-19 | 2012-09-18 | Sunovion Pharmaceuticals Inc. | L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
US8268832B2 (en) * | 2007-12-19 | 2012-09-18 | Sunovion Pharmaceuticals Inc. | Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
CA2812705C (en) * | 2007-12-19 | 2015-08-18 | Sunovion Pharmaceuticals Inc. | Maleate, besylate and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
EP2391354B1 (en) | 2009-01-30 | 2019-11-27 | Sunovion Pharmaceuticals Inc. | Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrol o [3,4-b] pyrazine and process for preparation thereof |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
CN105399745A (zh) * | 2015-12-17 | 2016-03-16 | 天津华津制药有限公司 | 一种吡嗪并羟基吡咯烷酮类化合物的制备方法 |
EP3468545A4 (en) | 2016-06-08 | 2020-07-22 | President and Fellows of Harvard College | METHODS AND COMPOSITIONS FOR REDUCING TACTILE DYSFUNCTION AND ANXIETY RELATED TO AUTISM SPECTRUM DISORDER, RETT SYNDROME AND FRAGILE X SYNDROME |
CN106220630B (zh) * | 2016-07-23 | 2019-12-10 | 迪嘉药业集团有限公司 | 一种n-取代吡咯并[3,4-b]吡嗪-5,7(6h)-二酮的制备方法 |
CA3099791A1 (en) * | 2018-05-29 | 2019-12-05 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
-
1972
- 1972-12-14 OA OA54780A patent/OA04285A/xx unknown
- 1972-12-28 DD DD167951A patent/DD102698A5/xx unknown
- 1972-12-29 NL NL7217852A patent/NL7217852A/xx unknown
- 1972-12-29 US US319876A patent/US3862149A/en not_active Expired - Lifetime
-
1973
- 1973-01-04 IL IL41232A patent/IL41232A/xx unknown
- 1973-01-04 IE IE12/73A patent/IE37056B1/xx unknown
- 1973-01-04 AU AU50754/73A patent/AU466586B2/en not_active Expired
- 1973-01-04 HU HURO691A patent/HU164821B/hu unknown
- 1973-01-05 CY CY915A patent/CY915A/xx unknown
- 1973-01-05 NO NO62/73A patent/NO136843C/no unknown
- 1973-01-05 AR AR246000A patent/AR195097A1/es active
- 1973-01-05 LU LU66800A patent/LU66800A1/xx unknown
- 1973-01-05 DE DE2300491A patent/DE2300491C3/de not_active Expired
- 1973-01-05 FI FI27/73A patent/FI54124C/fi active
- 1973-01-05 GB GB79073A patent/GB1358680A/en not_active Expired
- 1973-01-05 CA CA160,620A patent/CA991183A/fr not_active Expired
- 1973-01-05 DK DK6973AA patent/DK139359B/da not_active IP Right Cessation
- 1973-01-05 JP JP48000069A patent/JPS523952B2/ja not_active Expired
- 1973-01-05 AT AT10073A patent/AT323181B/de active
- 1973-01-05 BE BE793730D patent/BE793730A/xx active Protection Beyond IP Right Term
- 1973-01-05 SE SE7300159A patent/SE398503B/xx active Protection Beyond IP Right Term
-
1976
- 1976-09-08 JP JP51106831A patent/JPS5248687A/ja active Granted
- 1976-09-08 JP JP51106832A patent/JPS5248688A/ja active Granted
-
1977
- 1977-12-01 HK HK600/77A patent/HK60077A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPS5248688A (en) | 1977-04-18 |
DE2300491B2 (de) | 1977-09-08 |
SE398503B (sv) | 1977-12-27 |
NL7217852A (xx) | 1973-07-10 |
BE793730A (fr) | 1973-07-05 |
AU5075473A (en) | 1974-07-04 |
DK139359C (xx) | 1979-07-09 |
CA991183A (fr) | 1976-06-15 |
IL41232A (en) | 1975-12-31 |
NO136843C (no) | 1977-11-16 |
DK139359B (da) | 1979-02-05 |
FI54124B (fi) | 1978-06-30 |
DD102698A5 (xx) | 1973-12-20 |
LU66800A1 (xx) | 1973-07-18 |
IL41232A0 (en) | 1973-03-30 |
NO136843B (no) | 1977-08-08 |
JPS523952B2 (xx) | 1977-01-31 |
IE37056B1 (en) | 1977-04-27 |
HU164821B (xx) | 1974-04-11 |
GB1358680A (en) | 1974-07-03 |
FI54124C (fi) | 1978-10-10 |
JPS5248687A (en) | 1977-04-18 |
US3862149A (en) | 1975-01-21 |
AU466586B2 (en) | 1975-10-30 |
AT323181B (de) | 1975-06-25 |
JPS535315B2 (xx) | 1978-02-25 |
OA04285A (fr) | 1979-12-31 |
DE2300491C3 (de) | 1978-05-18 |
DE2300491A1 (de) | 1973-07-19 |
JPS4876892A (xx) | 1973-10-16 |
JPS5231358B2 (xx) | 1977-08-13 |
IE37056L (en) | 1973-07-07 |
HK60077A (en) | 1977-12-09 |
AR195097A1 (es) | 1973-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK60077A (en) | Pyrrolo (3,4-b) pyrazine derivatives | |
CA989843A (en) | 2-alkyl-3-acyl-pyrazolo(1,5-a) pyridines | |
PH10625A (en) | 1,3,4,9-tetrahydropyrano-or 1,3,4,9-tetrahydrothiopyrano-(3,4-b)indole derivatives | |
CA999860A (en) | Imidazo-(1,2-a)-(benzodiazepine-1,4) compounds | |
HK4080A (en) | Imidazo(4,5-b)pyridines | |
ZA745673B (en) | S-triazol(1,5-a) pyridine derivative | |
CA1010032A (en) | Imidazo (3,4-d)-dibenzo-oxazepines, -thiazepines, and -diazepines | |
ZA727468B (en) | Pyrrolo(3,4-b)pyridine derivatives | |
ZA74734B (en) | Imidazo(1,2-a)azacycloalkanes | |
CA1013747A (fr) | Procede de preparation de derives du 9h-pyrido/3,4-b/indole | |
CA970373A (en) | Pyrazolo (3,4-b) pyridine-5-carboxamides | |
HK50278A (en) | 1,4-dithiino(2,3-c)pyrrole derivatives | |
ZA7372B (en) | Pyrrolo(3,4-b)pyrazine derivatives | |
AU465283B2 (en) | PYRIDO 4, 3-c PYRIDAZINE COMPOUNDS | |
PH11677A (en) | 6,7,8,9-tetrahydro-1h-pyrazolo(3,4-b)(1,5)diazocine derivatives | |
AU475861B2 (en) | 6-phenyl-4h-v-triazolo /1,5-a/1,4/ benzodiazepines | |
CA925510A (en) | (pyrazolo(3,4-b)pyridin-5-yl-formamidoethyl) phenylsulfonylureas | |
CA979901A (en) | 1,2-dihydro-2-oxopyrimido (4,5-b) quinoxaline derivatives | |
ZA726070B (en) | New process for the preparation of s.triazolo(4,3-a)pyridine derivatives | |
ZA716300B (en) | Imidazo(4,5-b)pyridine derivatives | |
CA893707A (en) | Pyrazine derivatives | |
IE35664B1 (en) | Imidazo (4,5-b) pyridine derivatives | |
AU420900B2 (en) | OXAZOLO(3, 2a) PYRROLO (2,1-a) PYRAZINE DERIVATIVES PREPARATION THEREOF | |
CA810220A (en) | 1h-pyrazolo(3,4-b) pyridines | |
CA884895A (en) | Thiazolo (3,2-a) pyrimidine derivatives |